Advertisement

Topics

NICE recommends Celgene’s pancreatic cancer treatment abraxane for NHS use

19:00 EDT 7 Aug 2017 | Pharmaceutical Technology

The UK National Institute for Health and Care Excellence (NICE) has recommended the routine use of Celgene’s nab-paclitaxel as a life-extending treatment for patients with progressive pancreatic cancer that has progressed.

Original Article: NICE recommends Celgene’s pancreatic cancer treatment abraxane for NHS use

NEXT ARTICLE

More From BioPortfolio on "NICE recommends Celgene’s pancreatic cancer treatment abraxane for NHS use"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pancreatitis
Pancreatitis Acute pancreatitis is inflammation of the pancreas caused by the release of activated pancreatic enzymes. Common triggers are biliary tract disease and chronic heavy alcohol intake.  Diagnosis is based on clinical presentation...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...